Device type · NQI
System, Immunomagnetic, Circulating Cancer Cell, Enumeration
Last checked: Nov 20, 2026Source: openFDAMethods & limitations
Product code
NQI
Pathology
Device class
Class II
FDA decisions since 2015
0
510(k), De Novo and PMA
Adverse event reports
0
Received Nov 1, 2025 to Nov 20, 2026
How FDA classifies it
- Device type
- System, Immunomagnetic, Circulating Cancer Cell, Enumeration
- Product code
- NQI
- Device class
- Class II
- Review panel
- Pathology
- Regulation
- 21 CFR 866.6020
- Specialty
- Laboratory Medicine & Pathology
- FDA record
- Classification database entry for NQI
Latest FDA decisions
No 510(k), De Novo or PMA decisions for this product code since 2015.
Reports received
0
Received Nov 1, 2025 to Nov 20, 2026
Malfunction reports
0
Injury reports
0
Death reports
0
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
No reports to chart for this view.
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
No manufacturers to rank.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
No device problems coded.
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
No patient problems coded.
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-1345-2022 · Started May 20, 2022
Reason given: High number of total images/unassigned events including (dual positives) and the potential for false positive results being placed into the image gallery in some patient samples
Cause as FDA categorized it: Process control
Z-1530-2018 · Started Apr 4, 2018
Reason given: Unusually high number of total images/unassigned events may require additional time and effort for the operator to review all the images and may cause a delay in reporting the results.
Cause as FDA categorized it: Process design
Z-2406-2015 · Started May 15, 2015 · Posted by FDA Aug 18, 2015
Reason given: Complaints of the presence of artifacts that appears as small bead like structures in the image gallery when processing both control cells and patient samples as well as the failure of high control cells.
Cause as FDA categorized it: Under Investigation by firm
6 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.